D-149-2013 Class II Terminated

Recalled by West-Ward Pharmaceutical Corp. — Eatontown, NJ

FDA drug recall D-149-2013 was initiated by West-Ward Pharmaceutical Corp. on Dec 5, 2012 and is designated Class II. Reason for recall: Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets. The recall status is terminated (terminated Mar 18, 2015). Affected quantity: 128,319 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 13, 2013
Initiation Date
Dec 5, 2012
Termination Date
Mar 18, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
128,319 bottles

Product description

PredniSONE Tablets, USP, 10 mg, packaged in a) 100-count tablets per bottle (NDC 0143-1473-01), b) 1000-count tablets per bottle (NDC 0143-1473-10), Rx only, Manufactured by: West-ward Pharmaceutical Corp., Eatowntown, NJ 07724.

Reason for recall

Presence of Foreign Substance: Tablets are being recalled due to gray defects identified in the tablets.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: 69403A, 69403B, Exp 10/15; 69404A, 69405A, 69515A, 69702A, 69702B, 69703A, Exp 11/15; 69767A, 69767B, Exp 12/15

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-149-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-149-2013. Report a data issue: hello@regdatalab.com.